Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-22 Sale |
2022-02-24 4:28 pm |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
11,228 | $2.4188 | $27,158 | 569,780 (Direct) |
View |
| 2021-10-05 Sale |
2021-10-05 5:34 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
494,780 | $0 | $0 | 0 (Direct) |
View |
| 2021-04-12 Sale |
2021-04-13 5:06 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
10,000 | $4.0725 | $40,725 | 496,824 (Direct) |
View |
| 2021-01-13 Sale |
2021-01-15 4:03 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
10,000 | $6.0058 | $60,058 | 406,824 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 4:02 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
10,000 | $5.7244 | $57,244 | 416,824 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-31 Option Award |
2023-02-01 4:12 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
150,000 | $0 | 719,780 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-24 4:28 pm |
2022-02-22 2022-02-23 |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
11,228 | $0 | 569,780 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-24 4:28 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
11,228 | $0.69 | 569,780 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:15 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
75,000 | $0 | 569,780 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:46 pm |
N/A 2022-02-23 |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
609,382 | $0 | 609,382 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:17 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
100,000 | $0 | 506,824 (Direct) |
View |
| 2020-12-16 Gift |
2020-12-17 4:40 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
10,000 | $0 | 426,824 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-17 4:26 pm |
N/A 2030-08-14 |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
25,000 | $0 | 461,824 (Direct) |
View |